CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,285 | -18.5% | 19,479 | -3.1% | 0.00% | – |
| Q2 2023 | $216,362 | +96.7% | 20,108 | +87.1% | 0.00% | – |
| Q1 2023 | $109,973 | -3.0% | 10,750 | +0.0% | 0.00% | – |
| Q4 2022 | $113,381 | -16.0% | 10,747 | +1.7% | 0.00% | – |
| Q3 2022 | $135,000 | +0.7% | 10,563 | +1.4% | 0.00% | – |
| Q2 2022 | $134,000 | +2.3% | 10,419 | -15.9% | 0.00% | – |
| Q1 2022 | $131,000 | -35.8% | 12,389 | -6.1% | 0.00% | – |
| Q4 2021 | $204,000 | -5.1% | 13,187 | +38.3% | 0.00% | – |
| Q3 2021 | $215,000 | -7.7% | 9,534 | +5.6% | 0.00% | – |
| Q2 2021 | $233,000 | – | 9,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |